225 related articles for article (PubMed ID: 22825900)
41. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.
Ivy DD; Doran AK; Smith KJ; Mallory GB; Beghetti M; Barst RJ; Brady D; Law Y; Parker D; Claussen L; Abman SH
J Am Coll Cardiol; 2008 Jan; 51(2):161-9. PubMed ID: 18191742
[TBL] [Abstract][Full Text] [Related]
42. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
N Engl J Med; 2000 Jun; 342(25):1866-70. PubMed ID: 10861321
[TBL] [Abstract][Full Text] [Related]
43. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
[TBL] [Abstract][Full Text] [Related]
44. Role of Vasodilator Testing in Pulmonary Hypertension.
Sharma A; Obiagwu C; Mezue K; Garg A; Mukherjee D; Haythe J; Shetty V; Einstein AJ
Prog Cardiovasc Dis; 2016; 58(4):425-33. PubMed ID: 26434988
[TBL] [Abstract][Full Text] [Related]
45. Inhaled Therapies for Pulmonary Hypertension.
Hill NS; Preston IR; Roberts KE
Respir Care; 2015 Jun; 60(6):794-802; discussion 802-5. PubMed ID: 26070575
[TBL] [Abstract][Full Text] [Related]
46. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects.
Journois D; Pouard P; Mauriat P; Malhère T; Vouhé P; Safran D
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1129-35. PubMed ID: 8159035
[TBL] [Abstract][Full Text] [Related]
47. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.
Sablotzki A; Czeslick E; Gruenig E; Friedrich I; Schubert S; Börgermann J; Hentschel T
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):960-2. PubMed ID: 12698166
[No Abstract] [Full Text] [Related]
48. [Aerosolized iloprost therapy in an infant with chronic pulmonary hypertension after a neonatal arterial switch operation].
Lambert V; Serraf A; Durand P; Losay J
Arch Pediatr; 2001 Nov; 8(11):1218-21. PubMed ID: 11760674
[TBL] [Abstract][Full Text] [Related]
49. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
[TBL] [Abstract][Full Text] [Related]
50. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.
Zhang DZ; Zhu XY; Meng J; Xue HM; Sheng XT; Han XM; Cui CS; Wang QG; Zhang P
Int J Cardiol; 2011 Mar; 147(3):433-7. PubMed ID: 20537740
[TBL] [Abstract][Full Text] [Related]
51. Inhaled iloprost for the control of pulmonary hypertension.
Krug S; Sablotzki A; Hammerschmidt S; Wirtz H; Seyfarth HJ
Vasc Health Risk Manag; 2009; 5(1):465-74. PubMed ID: 19475782
[TBL] [Abstract][Full Text] [Related]
52. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease.
Day RW; Hawkins JA; McGough EC; Crezeé KL; Orsmond GS
Ann Thorac Surg; 2000 Jun; 69(6):1907-12; discussion 1913. PubMed ID: 10892945
[TBL] [Abstract][Full Text] [Related]
53. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease.
Russell IA; Zwass MS; Fineman JR; Balea M; Rouine-Rapp K; Brook M; Hanley FL; Silverman NH; Cahalan MK
Anesth Analg; 1998 Jul; 87(1):46-51. PubMed ID: 9661544
[TBL] [Abstract][Full Text] [Related]
54. A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.
Theodoraki K; Thanopoulos A; Rellia P; Leontiadis E; Zarkalis D; Perreas K; Antoniou T
Heart Vessels; 2017 Dec; 32(12):1488-1497. PubMed ID: 28717881
[TBL] [Abstract][Full Text] [Related]
55. The effects of perioperative inhaled iloprost on pulmonary hypertension with congenital heart disease.
Sung KW; Jeon YB; Kim NY; Park KY; Park CH; Choi CH; Choi DY
Cardiology; 2013; 126(4):224-9. PubMed ID: 24081196
[TBL] [Abstract][Full Text] [Related]
56. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.
Max M; Kuhlen R; Dembinski R; Rossaint R
Intensive Care Med; 1999 Oct; 25(10):1147-54. PubMed ID: 10551974
[TBL] [Abstract][Full Text] [Related]
57. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
[TBL] [Abstract][Full Text] [Related]
58. Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.
Olschewski H; Ghofrani HA; Walmrath D; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Intensive Care Med; 1998 Jun; 24(6):631-4. PubMed ID: 9681789
[TBL] [Abstract][Full Text] [Related]
59. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
[TBL] [Abstract][Full Text] [Related]
60. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
Rex S; Schaelte G; Metzelder S; Flier S; de Waal EE; Autschbach R; Rossaint R; Buhre W
Acta Anaesthesiol Scand; 2008 Jan; 52(1):65-72. PubMed ID: 17976224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
